Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 03, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Announces Opening of Manufacturing Facility and Production Milestone Achievement

DUBLIN, Ireland, June 03, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics developer, today announced the official opening of BioNua Limited, its...
May 27, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Provides Update on Upcoming Investor Symposium at Irish Biomanufacturing Facility

DUBLIN, Ireland, May 27, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, is pleased to provide an update on its Investor Symposium, which...
May 26, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Announces Positive Results from NV-02 Pilot Field Study in Cats with Osteoarthritis

DUBLIN, Ireland, May 26, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, today announced statistically significant efficacy results from its...
May 12, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2016

DUBLIN, Ireland, May 12, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced its financial results for the three and nine-month periods ended...
May 11, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet to Host Symposium at American College of Veterinary Internal Medicine (ACVIM) Forum to Present Additional NV-01 Pivotal Data in Canine Pain and Clinical Data for NV-02 in Feline Pain

DUBLIN, Ireland, May 11, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced it will host a symposium to present expanded pivotal safety and...
May 04, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet to Host Investor Symposium at its Irish Biomanufacturing Facility

DUBLIN, Ireland, May 04, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced the hosting of an Investor Symposium on June 3, 2016 at BioNua,...
May 02, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet and Zenoaq Announce PD-1 mAb Candidate for Canine Cancer

DUBLIN, Ireland, May 02, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, and Zenoaq (Nippon Zenyaku Kogyo Co., Ltd.), a leading Japanese animal health...
March 08, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Announces Successful Completion of NV-01 Pilot Field Study in Dogs With Osteoarthritis

DUBLIN, Ireland, March 08, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced the successful completion of its pilot field study for...
February 29, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet to Present at the Cowen and Company 36th Annual Health Care Conference

DUBLIN, Ireland, Feb. 29, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapy developer, today announced that its Chief Executive Officer, Dr. Mark Heffernan, is...
February 16, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2016

DUBLIN, Ireland, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced its financial results for the three and six month periods ended...